Mecain

Mepivacaine Hydrochloride, the active ingredient in Mecain, is a local anesthetic presented as a sterile injectable solution for epidural, infiltration, intradermal and subcutaneous use. It provides rapid onset reversible nerve block for dental procedures and various surgical interventions in adult patients.

GNH USA supplies Mecain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable logistics to meet global demand. Clients benefit from consistent product quality, regulatory support, and responsive technical assistance throughout the supply chain.

Mepivacaine Hydrochloride is a local anesthetic used to achieve reversible nerve block in dental and surgical settings.

Dental procedures: provides local anesthesia for tooth extractions, restorations and periodontal surgery. Surgical procedures (regional anesthesia): enables regional anesthesia for minor orthopedic and soft‑tissue surgeries. Epidural anesthesia: used for epidural analgesia during obstetric labor and postoperative pain control.

Adverse reactions to Mecain are generally related to its anesthetic action and formulation.

Common Side Effects: - Tingling or numbness at the injection site - Light‑headedness or dizziness - Nausea or metallic taste - Transient hypotension

Serious or Rare Side Effects: - Allergic reaction including anaphylaxis - Cardiac arrhythmia or severe hypotension - Seizures or central nervous system toxicity

Mecain should be used with careful clinical assessment and monitoring.

Allergy assessment: review patient history for hypersensitivity to amide‑type anesthetics. Cardiac monitoring: use cautiously in patients with cardiac conduction disorders. Intravascular injection: avoid accidental intravascular administration to prevent systemic toxicity. Pregnancy consideration: use only if benefit outweighs potential risk, as safety data are limited. Store below 25°C: keep in the original container, protect from light and moisture.

Mecain may interact with other drugs that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) - Other amide local anesthetics administered concurrently - High‑dose epinephrine formulations

Moderate Interactions (Monitor Closely): - CYP450 inhibitors such as cimetidine that may increase plasma levels - Anticoagulants where bleeding risk may be heightened